The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors

Leuk Lymphoma. 2019 Jul;60(7):1842-1844. doi: 10.1080/10428194.2018.1551540. Epub 2019 Feb 18.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Drug-Related Side Effects and Adverse Reactions / diagnosis*
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Follow-Up Studies
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Medication Adherence / statistics & numerical data*
  • Patient Reported Outcome Measures
  • Pilot Projects
  • Prognosis
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Self-Management*
  • Telemedicine / statistics & numerical data*

Substances

  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases